ONCOLYTICS BIOTECH INC's ticker is ONCYF and the CUSIP is 682310107. A total of 30 filers reported holding ONCOLYTICS BIOTECH INC in Q3 2014. The put-call ratio across all filers is 3.09 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2014 | $591,000 | -18.1% | 1,106,000 | -12.0% | 0.00% | 0.0% |
| Q3 2014 | $722,000 | -57.2% | 1,256,300 | +1.6% | 0.00% | -66.7% |
| Q2 2014 | $1,688,000 | +11.5% | 1,237,100 | +23.0% | 0.00% | 0.0% |
| Q1 2014 | $1,514,000 | -2.5% | 1,005,900 | 0.0% | 0.00% | 0.0% |
| Q4 2013 | $1,553,000 | +117.5% | 1,005,900 | +242.8% | 0.00% | +200.0% |
| Q3 2013 | $714,000 | -67.6% | 293,400 | -62.1% | 0.00% | -75.0% |
| Q2 2013 | $2,204,000 | – | 773,300 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXT Financial Group, Inc | 43,000 | $19,000 | 0.01% |
| VSR Financial Services, Inc. | 119,630 | $54,000 | 0.01% |
| TCI Wealth Advisors, Inc. | 1,200 | $1,000 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 11,944 | $5,000 | 0.00% |
| STIFEL FINANCIAL CORP | 24,500 | $11,000 | 0.00% |
| FIRST MANHATTAN CO. LLC. | 1,000 | $0 | 0.00% |
| WELLS FARGO & COMPANY/MN | 1,000 | $0 | 0.00% |
| GROUP ONE TRADING, L.P. | 38,529 | $18,000 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 44,017 | $20,000 | 0.00% |
| HOWE & RUSLING INC | 1,017 | $0 | 0.00% |